Related by context. All words. (Click for frequent words.) 73 osteosarcomas 71 GISTs 70 HbF 69 ADPKD 69 astrocytomas 69 medulloblastomas 68 inherited mutations 68 meningiomas 68 hamartomas 68 GIST tumors 68 MYCN amplification 68 neurofibromas 67 adenocarcinomas 67 sarcomas 67 serous ovarian cancer 67 GBM tumors 67 bladder cancers 67 neoplasms 67 anaplastic 67 Gliomas 67 nonmelanoma skin cancers 66 Glioblastoma multiforme GBM 66 chromosomal rearrangement 66 medulloblastoma 66 epithelial tumors 66 NF1 66 ependymomas 66 Acute lymphoblastic leukemia 66 leukemias lymphomas 66 Glioblastomas 66 primitive neuroectodermal tumors 66 ependymoma 66 mtDNA mutations 66 medulloblastoma tumors 66 GBMs 66 pheochromocytoma 66 Carcinoid tumors 66 basal cell nevus syndrome 66 gastric cancers 66 MGUS 66 renal cell carcinomas 66 hepatocellular carcinomas 65 basal cell carcinomas 65 seminomas 65 Synovial sarcoma 65 hepatoma 65 gastric carcinoma 65 Hashimoto thyroiditis 65 spontaneously regress 65 pancreatic adenocarcinoma 65 paraganglioma 65 grade gliomas 65 Meningiomas 65 atypical hyperplasia 65 leukaemias 65 Glioblastoma Multiforme GBM 65 Sjögren syndrome 65 subependymal giant cell 65 somatic mutations 65 malignant prostate 65 invasive ductal 65 metastatic melanomas 65 schwannomas 64 Papillary 64 Glioma 64 EoE 64 molecular abnormalities 64 cisplatin resistant 64 endometrial cancers 64 lipomas 64 EBV infection 64 acute leukemias 64 teratoma 64 radiosensitive 64 Leukemias 64 germline mutations 64 neoplasm 64 Genetic variants 64 familial pancreatic cancer 64 chronic eosinophilic leukemia 64 idiopathic PAH 64 hyperplastic 64 NKT cells 64 MALT lymphoma 64 pilocytic astrocytomas 64 astrocytoma 64 Basal cell 64 paragangliomas 64 neuroblastoma tumors 64 colorectal tumors 64 missense mutations 64 oligodendrogliomas 64 untreated celiac disease 64 Hurler syndrome 64 squamous cell carcinoma SCC 64 pancreatic endocrine 64 Wilms tumor 64 lymphomas 64 ataxias 64 leukemia ALL 64 Li Fraumeni syndrome 64 HER2 positive cancers 64 leiomyomas 64 immunocompetent 64 autosomal dominant inheritance 64 hypereosinophilic syndrome 64 narcolepsy cataplexy 64 childhood leukemias 63 brain lesions 63 gastrointestinal stromal tumors GISTs 63 carcinoid 63 myopathies 63 fibromatosis 63 EGFR inhibitors 63 lichen planus 63 PTPN# 63 HER2 overexpression 63 mitochondrial disorders 63 basal cell skin 63 HLA B# 63 tumors 63 vWD 63 basal cell carcinoma BCC 63 breast carcinomas 63 uterine tumors 63 KRAS oncogene 63 p# mutations 63 sarcomatoid 63 juvenile idiopathic arthritis JIA 63 metastatic lesions 63 PDGFR 63 acute lymphoid leukemia 63 lymphoproliferative disorders 63 PARP inhibition 63 bronchogenic carcinoma 63 ALK mutations 63 haematopoietic 63 GBA mutations 63 mammary tumors 63 WT1 63 supratentorial 63 JAK2 enzyme 63 lymphocytic 63 KCNH2 63 atrophic gastritis 63 mammary cancers 63 de novo mutations 63 renal tumors 63 gene rearrangements 63 node metastases 63 papillary renal cell carcinoma 63 BRAF gene 63 herpesviruses 63 GSTP1 63 premalignant 63 CMV infection 63 seminoma 63 HGPS 63 prostate adenocarcinoma 63 familial ALS 63 embryonal rhabdomyosarcoma 63 T1DM 63 squamous cell lung cancer 63 LRP5 63 interleukins 63 ERK signaling 63 myeloma cells 63 PNET 63 Fibroblasts 63 ductal breast cancer 63 Glucocorticoids 63 myeloproliferative diseases 63 ovarian tumors 63 histiocytosis 63 acute myelogenous leukemia AML 63 autoinflammatory diseases 63 highly vascularized 63 normal karyotype 63 metaplasia 63 Epstein Barr virus EBV 62 metastatic neuroendocrine tumors 62 intestinal polyps 62 basal cell cancers 62 malignant neoplasm 62 mononuclear cells 62 IgA deficiency 62 uveal melanoma 62 EGFR mutant 62 IGFBP 3 62 androgen receptor AR 62 neoplastic cells 62 neuroendocrine tumors 62 TMEM#B 62 KIT mutations 62 anemias 62 myelofibrosis polycythemia vera 62 FLT3 62 hypermethylation 62 malignancies 62 breast carcinoma 62 Fas ligand 62 NOTCH1 62 herpes simplex encephalitis 62 testicular cancers 62 malignant tumors 62 urothelial carcinoma 62 JAK mutations 62 pDCs 62 myelomas 62 CYT# potent vascular disrupting 62 hematologic toxicity 62 GPC5 62 Hemangiomas 62 glioblastoma tumors 62 methicillin susceptible Staphylococcus aureus 62 alveolar rhabdomyosarcoma 62 Squamous 62 grade cervical intraepithelial 62 ovarian carcinoma 62 mutated K ras 62 activating mutations 62 cervical lymph nodes 62 neurofibroma 62 Glioblastoma multiforme 62 hematopoietic cancers 62 Philadelphia Chromosome Positive 62 monogenic 62 kidney urologic 62 Medulloblastoma 62 tumoral 62 thyroid cancers 62 CYP #A# 62 synovial sarcoma 62 Endometrial cancer 62 Tumours 62 Metastases 62 Atypical antipsychotics 62 CLL cells 62 sporadic ALS 62 Leydig cell 62 post transplant lymphoproliferative 62 MAPK pathway 62 idiopathic myelofibrosis 62 immunodeficiency 62 BRCA1 BRCA2 62 metastatic tumors 62 juvenile myelomonocytic leukemia 62 lung carcinomas 62 oncoproteins 62 squamous cell cancers 62 prostate carcinoma 62 metabolic abnormalities 62 V#F mutation 62 plexiform neurofibromas 62 pulmonary metastases 62 myeloproliferative neoplasms 62 neoplasias 62 proband 62 soft tissue sarcomas 62 BMPR2 62 pituitary adenomas 62 infantile hemangiomas 62 malignant lymphomas 62 desmoplastic 62 invasive carcinoma 62 nonhereditary 62 JMML 62 atherosclerotic lesions 62 Genetic mutations 62 CagA 62 pulmonary metastasis 62 autosomal recessive 62 mosaicism 62 Squamous cell carcinomas 62 H. pylori infections 62 myeloid leukemia 62 neuroendocrine cancers 62 angiosarcoma 62 Th2 cytokines 62 nasopharyngeal carcinoma 62 lobular breast cancer 62 generalized seizures 62 glioma cells 62 activating mutation 62 carcinoids 62 malignant growths 62 IDH1 mutation 62 chromosomal anomalies 62 ductal cancer 62 chromosomal defect 62 p# activation 61 benign neoplasms 61 bone marrow mesenchymal stem 61 chromosomal aberrations 61 Hurthle cell 61 neuroendocrine carcinoma 61 melanocytic nevi 61 chronic granulomatous disease 61 lymphoid tissue 61 PTEN mutations 61 Aspergillus species 61 essential thrombocythemia 61 colorectal carcinoma 61 thyroid carcinoma 61 Anaplastic 61 intracranial tumors 61 lymphoblastic leukemia 61 carbohydrate antigens 61 advanced adenomas 61 NF2 61 prostate pancreatic 61 NF kB pathway 61 mesotheliomas 61 Chronic lymphocytic leukemia 61 PDGFRA 61 squamous cell carcinomas 61 neurosensory 61 pituitary tumors 61 VHL gene 61 Clusterin 61 severe dehydrating diarrhea 61 endostatin 61 anti angiogenic drugs 61 papillomas 61 breast cancer subtypes 61 cytogenetic abnormalities 61 nonalcoholic steatohepatitis NASH 61 beta thalassemia 61 lobular carcinomas 61 Acute myeloid leukemia 61 beta1 integrin 61 chlamydial infection 61 gliomas 61 metastases 61 cranial irradiation 61 anthracycline chemotherapy 61 excitatory synapses 61 Malignant mesothelioma 61 Melanomas 61 HBeAg negative 61 skeletal metastases 61 hyperparathyroidism 61 gastric adenocarcinoma 61 hypermethylated 61 genetic syndromes 61 penetrance 61 mitochondrial mutations 61 Vidaza ® 61 incidentalomas 61 uPAR 61 Aortic stenosis 61 B7 H3 61 oncogenic transformation 61 neurological manifestations 61 vWF 61 MTHFR 61 transfusion syndrome 61 aneuploidies 61 familial hypercholesterolemia 61 microglial cells 61 Gorlin syndrome 61 anterior uveitis 61 glioblastomas 61 VUR 61 fibroma 61 leukoencephalopathy 61 genital tract infections 61 lung adenocarcinomas 61 K ras mutations 61 hematopoietic cells 61 Osteosarcoma 61 lobular carcinoma 61 umbilical hernias 61 malignant pancreatic 61 precursor lesions 61 leiomyoma 61 cell adhesion molecules 61 degenerative neurological diseases 61 elevated triglyceride levels 61 relapsed ALL 61 glial tumors 61 eccrine 61 lymphoma subtypes 61 colonic polyps 61 Gleevec resistant 61 acoustic neuromas 61 genomic alterations 61 onset diabetes mellitus 61 microdeletions 61 LRRK2 gene 61 mTOR inhibitors 61 liver metastasis 61 carcinomas 61 proto oncogene 61 histologically 61 staphylococcal infections 61 metalloprotease 61 generalized epilepsy 61 nucleoside analogues 61 p# mutation 61 NOMID 61 renal carcinoma 61 epigenetic alterations 61 mucus glands 61 intestinal epithelium 61 CDK4 61 systemic amyloidosis 61 postoperative delirium 61 peritoneal carcinomatosis 61 astrocytic 61 herpes viruses 61 G6PD 61 staphylococci 61 neoplasia 61 cerebral vasospasm 61 Uterine fibroids 61 Th2 cells 61 oesophageal adenocarcinoma 61 neuroinflammation 61 calculi 61 epilepsies 61 myeloid 61 ccRCC 61 synaptogenesis 61 C. trachomatis 61 holoprosencephaly 61 maternally inherited 61 interferon IFN 61 MLL gene 61 aneuploid cells 61 autosomal recessive disease 61 Streptococcus pyogenes 61 osteoid 61 NKX#.# 60 CD# + [001] 60 cyclin E 60 metastatic malignant 60 trans retinoic acid 60 pancreatic prostate 60 hypomethylation 60 Cockayne syndrome 60 rotaviruses 60 neurodegenerative disorder 60 Squamous cell 60 mutant huntingtin protein 60 esophageal tumors 60 Sezary syndrome 60 respiratory viral infections 60 Epstein Barr Virus EBV 60 multisystem disease 60 lung tumors 60 PIK3CA 60 fatal neuromuscular disorder 60 carcinoid tumors 60 breast cancer metastasis 60 thyrotropin 60 solar keratosis 60 eosinophilic 60 chronic periodontitis 60 mutated KRAS gene 60 ADAMTS# 60 VZV 60 nutlin 3a 60 FTLD 60 hypoperfusion 60 Upregulation 60 nodal metastasis 60 mucinous 60 mesenchymal cells 60 MDSCs 60 papillary carcinoma 60 ABCB1 60 gastrointestinal stromal tumor 60 vesicoureteral reflux 60 S. aureus isolates 60 epithelial cancers 60 pro angiogenic 60 neoplastic lesions 60 micrometastases 60 cranial radiation 60 cisplatin chemotherapy 60 c MET 60 polycystic ovarian syndrome PCOS 60 malignant brain 60 glycosylated 60 neurocognitive impairment 60 cancers 60 metastatic bladder 60 APOE ε4 60 MCAD deficiency 60 immunosuppressed 60 immunodeficiencies 60 cell adhesion molecule 60 mucins 60 candidemia 60 chronic HBV infection 60 Smac mimetic 60 Angelman syndrome 60 neuronal dysfunction 60 dyskeratosis congenita 60 amyloid deposits 60 anti epileptics 60 Malignant tumors 60 metastatic lymph nodes 60 proliferative diabetic retinopathy 60 vimentin 60 leiomyosarcoma 60 overt hypothyroidism 60 non coding RNA 60 lymphoid tumors 60 intracranial hemorrhage ICH 60 ruptured aneurysms 60 papillary 60 mycosis fungoides 60 neuroblastoma tumor 60 hereditary predisposition 60 ANCA associated 60 N. gonorrhoeae 60 Notch1 60 NSCLC tumors 60 homozygotes 60 costimulatory 60 mouse testes 60 motor neuron diseases 60 Cysts 60 Smad3 60 Kupffer cells 60 S. aureus infection 60 malignant lymphoma 60 rhabdomyosarcoma 60 Hutchinson Gilford progeria 60 Factor Receptor 60 Metastatic breast cancer 60 juvenile idiopathic arthritis 60 chromosomal anomaly 60 heterozygotes 60 N Myc 60 differentiated thyroid 60 breast endometrial 60 prostate cancer CaP 60 transcriptional repressor 60 histologic subtype 60 mammary cells 60 Pancreatic neuroendocrine tumors 60 nonmetastatic 60 germline mutation 60 HHV 6 60 BRCA1 mutations 60 Glioblastoma 60 #q#.# [001] 60 heterotaxy 60 thymectomy 60 IgA antibodies 60 endocrine tumors 60 recurrent glioblastoma multiforme 60 Waldenstrom macroglobulinemia 60 neurodevelopmental impairment 60 myeloproliferative disorders 60 extramedullary 60 c KIT 60 alveolar epithelial cells 60 IFNg 60 adenoma 60 BCR ABL mutations 60 Recurrences 60 DIPG 60 infantile hemangioma 60 arterial calcification 60 allelic variants 60 carotid plaques 60 sCJD 60 liver metastases 60 BRCA mutation carriers 60 Abeta# 60 progressive neurodegenerative disorder 60 Basal cell carcinoma 60 cortical dysplasia 60 sclerosing 60 colorectal carcinomas 60 TGFBR1 * 6A 60 TTR amyloidosis 60 Prion diseases 60 lymphoid 60 testicular tumors 60 lymphangiogenesis 60 epithelioid 60 SCN5A 60 malignant lesions 60 glomerulonephritis 60 PCNSL 60 genital herpes infections 60 protein kinase C 60 atypical hemolytic uremic syndrome 60 senescent cells 60 transgenic rats 60 CD#c 60 RET PTC rearrangements 60 IL 1ß 60 smoldering myeloma 60 downregulated 60 TCF#L# 60 recessive genetic 60 hyperinsulinism 60 malignant pleural mesothelioma 60 lymphoid cells 60 metachronous 60 osteoblastic 60 colorectal liver metastases 60 interferon pathway 60 indolent lymphomas 60 T2DM 60 chlamydial infections 60 GSTT1 60 Toxicities 60 monocytic 60 BCR ABL protein 60 meningeal 60 monocyte chemoattractant protein 60 immunosuppressed patients 60 FGFR4 60 HNSCC 60 adrenal cortex 60 generalized tonic clonic seizures 60 Cryptococcus neoformans 60 cell lymphomas 60 invasive ductal carcinoma 60 Hepatocellular Carcinoma HCC 60 Prostaglandins 60 cellular prion protein 60 molluscum contagiosum 60 fibrous dysplasia 60 lymphatic tissue 60 grade glioma 60 STAT4 60 leukemia AML 60 Immunohistochemical analysis 59 imatinib Gleevec 59 somatic mutation 59 lobular 59 PC# cells 59 carcinoid tumor 59 systemic mastocytosis 59 intestinal metaplasia 59 beta adrenergic receptors 59 neuronal stem cells 59 receptor subtype 59 prostate carcinomas 59 autoreactive T cells 59 von Hippel Lindau 59 developmental abnormalities 59 hepatoblastoma 59 HER2 receptor 59 orchitis 59 prostate cancers 59 typical antipsychotics 59 mutated genes 59 Autoimmune disorders 59 SIDS infants 59 Henoch purpura 59 choriocarcinoma 59 mu opioid 59 infective endocarditis 59 metabolic derangements 59 estrogen receptor beta 59 TAp# 59 granulocytes 59 Medullary thyroid cancer 59 neurological abnormalities 59 AAT deficiency 59 Prostatitis 59 hereditary hemochromatosis 59 ABCB1 gene 59 opportunistic pathogens 59 multidrug resistance 59 Genital herpes 59 colorectal cancer CRC 59 Heterozygous 59 glioblastoma multiforme GBM 59 microglial 59 neurogenic 59 VEGF receptor 59 Demodex 59 glucocorticoid receptors 59 MSH2 59 endometrial cells 59 EGFR mutations 59 Inappropriate activation 59 Adjuvant chemotherapy 59 cultured neurons 59 C#Y 59 poorer prognosis 59 sodium valproate 59 atherosclerotic disease 59 transgene expression 59 completely resected 59 postnatally 59 intraepithelial neoplasia 59 torsade de pointes 59 infarcts 59 leucopenia 59 Wilms tumors 59 pancreatic cancers 59 BRAF V#E 59 lung metastasis 59 gastric cardia 59 malignant transformation 59 mitochondrial toxicity 59 Neurofibromatosis type 59 lymphomas leukemias 59 EGFR protein 59 TET2 59 Rh incompatibility 59 TNFa 59 hyperkalemia 59 adenomatous 59 lysosomal storage disease 59 adhesion molecule 59 leukaemic stem cells 59 TACI mutations 59 ZNF# 59 precocious puberty 59 dexrazoxane 59 cutaneous squamous cell carcinoma 59 histological subtype 59 myofibroblasts 59 aldehyde dehydrogenase 59 oncogenic mutations 59 bleomycin 59 apoE4 59 TP# mutation 59 gastrointestinal dysfunction 59 bone marrow suppression 59 Anthracycline 59 hyperplasia 59 NFkB 59 elevated LDH 59 neurofibromatosis type 59 M. pneumoniae 59 cell acute lymphoblastic 59 alpha interferons 59 ADAM# 59 commonly mutated genes 59 hyperalgesia 59 TRAIL induced apoptosis 59 hemorrhagic cystitis 59 gastrointestinal cancers 59 neuropsychiatric disorder 59 otitis 59 neoplastic 59 pyelonephritis 59 virulence genes 59 International Prognostic Scoring 59 neurologic complications 59 metastatic lung cancer 59 gastrointestinal stromal tumors 59 lobular cancer 59 renal fibrosis 59 osteochondromas 59 NRTI resistance 59 epigenetic modification 59 C1q 59 BRCA1 mutation carriers 59 microdeletion 59 anti angiogenic agents 59 serine protease 59 Bleomycin 59 genetic abnormality 59 Rhabdomyosarcoma 59 B Cell Lymphoma 59 IPAH 59 phenothiazines 59 potent inhibitors 59 Anopheles gambiae mosquitoes 59 variceal bleeding 59 Chronic myeloid leukemia CML 59 vestibular schwannomas 59 artery embolization 59 perioperative complications 59 melanoma tumors 59 Cholangiocarcinoma 59 hypophosphatasia 59 radiosensitivity 59 EZH2 59 atopic disease 59 tumor metastases 59 myeloproliferative 59 vasopressin receptors 59 ORMDL3 59 isotypes 59 immunodeficient 59 FGFR1 59 Atopic dermatitis 59 somatostatin 59 invasive ductal breast cancer 59 Lrp5 59 pRb 59 VEGF inhibitors 59 diagnostic biomarker 59 enterocolitis 59 Wnt signaling pathway 59 prostate cancer metastases 59 adrenocortical cancer 59 spontaneous remission 59 epigenetically 59 BRAF mutation 59 intractable epilepsy 59 Hypophosphatasia 59 PKM2 59 Wwox 59 spontaneous mutations 59 ERK1 2 59 liver scarring 59 Wiskott Aldrich syndrome 59 neurotransmitter GABA 59 brain metastases 59 mutant p# 59 malignancy 59 fluoroquinolone resistance 59 OGG1 59 mesothelial cells 59 cell carcinomas 59 Becker muscular dystrophy 59 plasma kallikrein 59 oncoprotein 59 microvascular disease 59 hyperammonemia 59 trastuzumab resistant 59 folate metabolism 59 premalignant lesions 59 Plasmodium vivax 59 Severe Primary IGFD 59 Vitamin B# deficiency 59 xenograft tumors 59 dissociative disorders 59 hemangiomas 59 haematologic 59 eotaxin 59 ERBB2 59 thrombotic complications 59 extracranial 59 dominantly inherited 59 mental retardation epilepsy 59 paraneoplastic 59 epithelial tissues 59 E. faecalis 59 SSc 59 frequently benign tumor 59 plasmacytoid 59 lung metastases 59 TTR gene 59 MMP inhibitors 59 colorectal adenocarcinoma 59 acute lymphoblastic 59 Soft tissue sarcomas 59 CDH1 59 Juvenile Idiopathic Arthritis JIA 59 benign nodules 59 neuroblastoma 59 metastatic prostate 59 amyloid plaque formation 59 acne vulgaris 59 corticosteroid therapy 59 Treg cell 59 Colon polyps 59 Leber hereditary optic neuropathy 59 bowel cancers 59 microfilariae 59 susceptibility gene 59 aplasia 59 pre malignant lesions 59 TGF ß1 59 malignant fibrous histiocytoma 59 familial adenomatous polyposis FAP 59 neurological disorder affecting 59 mutant alleles 59 BCL#A 59 Uterine cancer 59 thrombocytopenia neutropenia 59 papular 59 IGFBP 59 EGFRvIII 59 oral squamous cell 59 vesicoureteral reflux VUR 59 imatinib resistance 59 behavioral disinhibition 59 HGPIN 59 dermatophytes 59 mRNA expression 59 pDC 59 A. fumigatus 59 hypogonadotropic hypogonadism 59 hamartoma 59 hepatocellular carcinoma HCC 59 muscular dystrophies 59 Thrombocytopenia 59 histone deacetylases 59 cytotoxic therapies 59 selective antagonists 59 chromosome #q#.# [001] 59 non metastatic osteosarcoma 59 dysregulated 59 phosphatases 59 removed laparoscopically 59 Propionibacterium acnes 59 cholangiocarcinoma 59 adenocarcinoma 59 RSV infections 59 hypovitaminosis D 59 clade B 59 Myelodysplastic syndromes MDS 59 varices 59 somatostatin receptors 58 DHFR 58 ErbB2 58 tumor suppressor protein 58 cytopathic 58 keloids 58 mutations 58 benign growths 58 DNA methylation patterns 58 RAS mutations 58 Systemic lupus erythematosus 58 DQB1 * 58 deacetylation 58 CMV infections 58 COX2 58 immunopathology 58 alkylating agents 58 FGFR2 58 febrile seizure 58 cardiac fibroblasts 58 multipotent 58 cardiac insufficiency 58 NF kappaB activation 58 granulomatous 58 ALI ARDS 58 tumor subtypes 58 urothelial bladder cancer 58 diagnosed glioblastoma multiforme 58 superficial bladder cancer 58 DFMO 58 thymoma 58 IgG4 58 gastric atrophy 58 ARVD 58 Cyclin D1 58 trophoblasts 58 Ribavirin causes 58 nicotinic receptor 58 TGF β 58 mutated KRAS 58 neurodevelopmental disorder 58 colon tumors 58 Mesenchymal 58 estrogen receptor negative 58 PAK1 58 papillary thyroid cancer 58 Mutational 58 penile cancers 58 Langerhans cell histiocytosis 58 FMRP protein 58 situ LCIS 58 epithelial ovarian 58 blastoma 58 leukemias 58 BRAF protein 58 pneumococcal infection 58 rebleeding 58 TGF ß 58 tuberous sclerosis TS 58 endocrine glands 58 beta catenin protein 58 JAK STAT signaling 58 P cadherin 58 Eisenmenger syndrome 58 lymphadenopathy 58 BMP4 58 p# deficient 58 mGluR 58 neutrophil counts 58 autoimmune encephalitis 58 Iron deficiency anemia 58 pseudotumor cerebri 58 peptidic 58 pleomorphic 58 inherited neurological disorder 58 Mitomycin C 58 proteoglycan 58 thrombi 58 KRAS mutations 58 #q#.# deletion syndrome 58 iNOS 58 von Willebrand 58 complement inhibitor eculizumab 58 male hormone androgen 58 pneumococci 58 Kufs disease 58 Sertoli cells 58 Uveal melanoma